Bio Rad Laboratories Inc (NYSE:BIO) under-valued by 13%
| Website | http://www.bio-rad.com/ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $17,533,698,048 |
| Beta | 0.807501 |
| Average Volume | $159,565 |
| Last Dividend | 0% |
| Price on Oct 29, 2021 | $663.16 |
| Autochartist™ Valuation | $751.15 |
| Conclusion |
13% under-valued |
| Download Report |
